Regadenoson
Regadenoson is an adenosine derivative and selective A2A adenosine receptor agonist with coronary vasodilating activity. Upon administration, regadenoson selectively binds to and activates the A2A adenosine receptor, which induces coronary vasodilation. This leads to an increase in coronary blood flow and enhances myocardial perfusion. Compared to adenosine, regadenoson has a longer half-life and shows higher selectivity towards the A2A adenosine receptor. This agent is a very weak agonist for the A1 adenosine receptor and has negligible affinity for the A2B and A3 adenosine receptors.
Product Specifications
CAS Number
313348-27-5
Product Name Alternative
CVT-3146 | Lexiscan
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO: 10 mM
Smiles
CNC (=O) C1=CN (N=C1) C2=NC3=C (C (=N2) N) N=CN3[C@H]4[C@@H] ([C@@H] ([C@H] (O4) CO) O) O
Molecular Formula
C15H18N8O5
Molecular Weight
390.35
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Explore Other Products
Browse additional items from our catalog
IKK alpha Recombinant Antibody, AbBy Fluor™ 647 Conjugated
Recombinant Schizosaccharomyces Pombe SPBC29A3.21 Protein (aa 1-100)
